Inhibition of Ras-GTPase signaling by FPTIII ameliorates development of cardiovascular dysfunction in diabetic-hypertensive rats

Vascular Pharmacology
M H M YousifSaghir Akhtar

Abstract

We studied the effect an inhibitor of Ras-GTPase (FPTIII, 1.5 mg/kg alt diem for 4 weeks) on mean arterial pressure (MAP), urine protein, vascular reactivity and cardiac function in streptozotocin (STZ)-induced diabetes in control normotensive (WKY) and spontaneously hypertensive rats (SHR). The increased urinary protein in STZ-treated WKY (D-WKY) and STZ-treated SHR (D-SHR) were significantly lower in FPTIII treated D-WKY and D-SHR. The abnormal vascular responsiveness to endothelin-1, angiotensin II, carbachol or histamine in isolated carotid artery from D-WKY and D-SHR was improved by chronic treatment with FPTIII. In isolated perfused hearts, recovery of left ventricular function from 40 min of global ischemia was significantly improved in FPTIII treated D-WKY and D-SHR. These results show that treatment with FPTIII can attenuate development of abnormal vascular reactivity and renal/cardiac dysfunction during simultaneous occurrence of hypertension and diabetes.

References

Nov 30, 1999·Trends in Pharmacological Sciences·E ZwickA Ullrich
Feb 28, 2002·Circulation·Giovanni CudaEnrico V Avvedimento
Jul 19, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Emily C RothsteinPamela A Lucchesi
Mar 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Bari MurtuzaMagdi H Yacoub
May 5, 2004·The Journal of Biological Chemistry·Takeshi AdachiRichard A Cohen
Aug 6, 2004·Endocrine Reviews·Zhi You FangThomas H Marwick
Dec 24, 2004·Current Opinion in Critical Care·Piero Pollesello, Alexandre Mebazaa
Jul 20, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ibrahim F BenterSaghir Akhtar
Sep 6, 2006·Hypertension·Sara GiuntiMark E Cooper
Sep 28, 2006·Nature Clinical Practice. Nephrology·Anil K Bidani, Karen A Griffin
Jul 3, 2007·Expert Opinion on Emerging Drugs·Yesid Alvarado, Francis J Giles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis